NuCana (NCNA) Total Non-Current Liabilities (2017 - 2025)

NuCana's (NCNA) quarterly Total Non-Current Liabilities came in at $949738.7 in Q4 2025, up 380.49% year-on-year from $197659.3 in Q4 2024, and up 496.48% quarter-over-quarter from $159224.7 in Q3 2025.

NuCana (NCNA) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

NuCana has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $949738.7 for Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $949738.7, up 380.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $949738.7 (up 380.49% YoY), and the FY2025 annual result was $941416.4, up 378.23% from the prior year.
  • Total Non-Current Liabilities came in at $949738.7 for Q4 2025 at NuCana, up from $159224.7 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $949738.7 in Q4 2025 to a low of $159224.7 in Q3 2025.
  • The 5-year median for Total Non-Current Liabilities is $299782.4 (2023), against an average of $352188.9.
  • Across the five-year window, Total Non-Current Liabilities sank 48.09% in 2021 and surged 380.49% in 2025, its largest moves.
  • NuCana's Total Non-Current Liabilities stood at $283082.2 in 2021, then soared by 83.14% to $518434.3 in 2022, then plunged by 40.63% to $307805.7 in 2023, then slumped by 35.78% to $197659.3 in 2024, then soared by 380.49% to $949738.7 in 2025.
  • The last three Total Non-Current Liabilities figures came in at $949738.7 (Q4 2025), $159224.7 (Q3 2025), and $182764.3 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 42,980.09
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 11.03 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.26 Bn 94.26 Bn - 64.76 Mn
10 NuCana 29.13 Bn 29.13 Bn - 949,738.67

Historic Data

Download Data
DateValue
Dec 31, 2025 949,738.67
Sep 30, 2025 159,224.73
Jun 30, 2025 182,764.26
Mar 31, 2025 171,292.07
Dec 31, 2024 197,659.28
Sep 30, 2024 213,085.23
Jun 30, 2024 267,590.80
Mar 31, 2024 291,759.18
Dec 31, 2023 307,805.67
Sep 30, 2023 354,671.74
Jun 30, 2023 421,709.38
Mar 31, 2023 481,341.77
Dec 31, 2022 518,434.32
Sep 30, 2022 595,166.89
Jun 30, 2022 206,527.53
Mar 31, 2022 250,923.28
Dec 31, 2021 283,082.23
Sep 30, 2021 332,238.59
Jun 30, 2021 387,170.73
Mar 31, 2021 471,590.91